AstraZeneca and Ionis’ stocks drop significantly on Wainua ATTR-CM trial failure
AstraZeneca and Ionis both saw their stocks take a hit on 9 July following the ATTR-CM trial failure.
AstraZeneca and Ionis both saw their stocks take a hit on 9 July following the ATTR-CM trial failure.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
